Residual or Recurrent Obstruction After Septal Myectomy
1 other identifier
observational
56
0 countries
N/A
Brief Summary
The goal of this observational study is to report the outcomes after septal myectomy in young children and infants and identify the mechanisms of residual or recurrent obstruction after surgery. in The main question\[s\] it aims to answer are:
- What is the early and mid-term results of septal myectomy in young children and infants with severe and extensive obstructive hypertrophic cardiomyopathy (HCM)?
- What are the mechanisms of residual or recurrent obstruction? Echocardiography and clinical course of children and infants under the age of 14 who underwent septal myectomy for hypertrophic obstructive cardiomyopathy from January 2013 to December 2020 will be followed up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2013
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2021
CompletedFirst Submitted
Initial submission to the registry
January 6, 2023
CompletedFirst Posted
Study publicly available on registry
January 18, 2023
CompletedJanuary 18, 2023
January 1, 2023
8 years
January 6, 2023
January 13, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
death
postoperative death during follow-up
through study completion, an average of 1 year
Secondary Outcomes (1)
recurrent obstruction
through study completion, an average of 1 year
Eligibility Criteria
Children with HOCM who remain severely symptomatic despite medical therapy or have a particularly high resting LVOT gradients (\>100mmHg) underwent septal myectomy by the same surgeon Y from January 2013 to December 2020. A total of 56 consecutive children younger than 14 were included. All patients were on Beta blockers therapy and symptomatic.
You may qualify if:
- Clinical diagnosis of hypertrophic obstructive cardiomyopathy (HOCM)
- Age young than 14 years
- Patients who have undergone septal myectomy
You may not qualify if:
- older than 14 years old;
- secondary left ventricular hypertrophy (LVH) related to subaortic stenosis or aortic stenosis.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Dong S, Du C, Song J, Dong J, Meng H, Xu H, Sun Y, Zou M, Li S, Yan J. Residual or recurrent obstruction after septal myectomy in young children and infants with hypertrophic cardiomyopathy: cohort study. Int J Surg. 2023 Jun 1;109(6):1699-1707. doi: 10.1097/JS9.0000000000000426.
PMID: 37165977DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 24 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
January 6, 2023
First Posted
January 18, 2023
Study Start
January 1, 2013
Primary Completion
December 31, 2020
Study Completion
February 1, 2021
Last Updated
January 18, 2023
Record last verified: 2023-01